EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Compliance to Competitive Advantage in Pharma Supply
Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser
Advisory Board
KNOWLEDGE BANK
-
Articles
Generative AI in Pharma: Scaling Productivity without Compromising
Most enterprise technologies enter a pharmaceutical company through a single door A manufacturing execution system arrives at a site A clinical data platform arrives in development Governance follows the deployment because there is a deployment to govern Generative AI did not behave this way It reached medical writers regulatory managers safety officers market access teams and commercial staff sim...
B2B Pharma Editorial Opportunities: Boosting Brand Visibility in Industry Magazines
The teams which previously counted greatly on banner advertisements email newsletters and sponsorship of various events are beginning to reevaluate the source of true influence Since such channels have a role to play they seldom earn credibility alone In contrast a wellplaced article in a respected industry publication can do something most campaigns struggle to achieveit makes people take you ser...
Pharma Event Marketing in Europe: Virtual & Hybrid Strategies to Drive High-Quality Leads
It is likely that you have attended some pharma event recently say in Frankfurt or Basel or even online and have noticed one thing Nothing wants lack of activity Booths are busy Webinars get registrations Virtual platforms show decent attendance numbers But when the dust settles a familiar problem shows up again
Pharmaceutical Business Strategy: Transformation, Regulation, Outsourcing and Growth
The pharmaceutical industry is standing at an unusual crossroads Patent cliffs are steeper regulators are tougher patients expect more transparency and payers are pushing back harder on price In this environment a strong Pharma Business Strategy is no longer a slide deck exercise for the boardroom its the difference between a company that scales globally and one that quietly fades into irrelevanc...
Intelligent Collaborations: Navigating the Current Biopharma M&A Rebound
Biopharma MA didnt collapse in and it recalibrated Deal volumes softened valuations compressed and acquirers grew cautious as macroeconomic headwinds elevated interest rates and regulatory scrutiny made largescale consolidation feel riskier than it once had But the underlying drivers never went away They accumulated
Brain Delivery of Biologics with Trojan Horse Shuttles: Remembering Paracelsus
Paracelsus in the th century established the principle of toxicology that the dose of a medicinal defines the difference between a remedy and a toxic effect
-
Techno Trends
Juniper Biosciences Secures FDA Breakthrough Designation
The US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to Juniper Biosciences JBS Ffluoromisonidazole or FMISO for identifying tumour hypoxia in patients with HPVpositive oropharyngeal carcinoma OPC
-
Projects
Onyx Scientific to Invest Over US$2 Million (£1.5 Million) in Sunderland GMP Facility Expansion
Onyx Scientific is investing more than US Million Million to expand its Good Manufacturing Practice GMP facilities at its Sunderland UK site The investment will increase capacity for commercial
-
Research Insights
One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases
Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies
-
whitepaper
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys
TOP ARTICLES
-
1
B2B Pharma Editorial Opportunities: Boosting Brand Visibility in Industry Magazines
Kate Williamson
B2B pharma editorial opportunities provide a reputable means of creating brand awareness via industry magazines. Through sponsored content and guest articles, companies are able to exchange knowledge,...
-
2
Pharma Event Marketing in Europe: Virtual & Hybrid Strategies to Drive High-Quality Leads
Kate Williamson
In Europe, pharma event marketing is becoming more data-driven, hybrid, and digital-first. In the case of virtual webinars to trade show, engagement quality and not quantity now determines success. Th...
-
3
Pharmaceutical Business Strategy: Transformation, Regulation, Outsourcing and Growth
Kate Williamson
This article explores how modern pharma business strategy blends strategic management, transformation, and outsourcing to drive sustainable growth. It examines evolving operating models, regulatory-dr...
-
4
Intelligent Collaborations: Navigating the Current Biopharma M&A Rebound
Doug Drysdale
The current biopharma M&A environment reflects a market under pressure from a $300 billion patent cliff, shifting regulatory conditions, and intensifying competition across novel modalities. This...
-
5
Brain Delivery of Biologics with Trojan Horse Shuttles: Remembering Paracelsus
William M. Pardridge
The development of biologics for the treatment of neural disorders has been slow, because these large molecule drugs do not cross the blood-brain barrier (BBB). Solutions to the BBB drug delivery prob...
press releases Read more...
Amneal Announces FDA Approval and Launch of Lanreotide Injection
Amneal Pharmaceuticals Inc Amneal or the Company NASDAQ AMRX today announced that the US Food and Drug Administration FDA has approved its lanreotide injection mg mL in a sterile
Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in TKI-Naïve Advanced ROS1-Positive Non-Small Cell Lung Cancer
Nuvation Bio Inc NYSE NUVB a global oncology company focused on tackling some of the toughest challenges in cancer treatment today announced that the US Food and Drug Administration FDA
Acelot Announces Initiation of Dosing in Phase Ia Clinical Trial of ACE-2223, a First-in-Class Oral Small Molecule Targeting Aggregated TDP-43 in Amyotrophic Lateral Sclerosis (ALS)
Acelot a biotechnology company developing small molecule therapies for challenging targets in diseases with high unmet need today announced the initiation of the Phase Ia clinical trial of ACE
Mission Bio Launches Tapestri® Triomics for Simultaneous DNA, RNA, and Protein Analysis at Single-Cell Resolution
Mission Bio a leader in singlecell multiomics today announced Tapestri Triomics a new expansion of the Tapestri Platform that simultaneously analyzes DNA RNA and protein in the same cell By connecting genotype
Events Read more...
21 - 23
Sep 2026Cell & Gene Therapy World Conference
Miami, Florida, USA
21 - 23
Sep 2026Cancer R&D World Conference
Hilton Garden Inn Miami Dolphi...
22 - 23
Sep 2026PDA Advanced Parenteral Therapeutics & Quality
Illume Hotel Taipei, Taiwan
22 - 24
Sep 2026InsurInnovator Connect Asia
Singapore
28 - 01
Sep 2026Discovery on Target 2026
Boston, MA, USA
29 - 01
Sep 202610th IPF Summit 2026
Boston, MA, USA
29 - 01
Sep 2026Powtech Technopharm 2026
Nuremberg, Germany
30 - 01
Sep 2026Pharma Launch Excellence Summit
Hyatt Regency Boston Harbor, B...
LATEST NEWS Read more...
BioCytics and Eremid collaborate on single-cell sequencing study for cancer cell therapy
BioCytics Inc has engaged Eremid Genomic Services to sequence an autologous immune cell fraction being developed for its immunebased cancer cell therapy programme
MAbxience and Sandoz collaborate to advance global access to emicizumab biosimilar
MAbxience majorityowned by Fresenius SE Co KGaA with partial ownership from Insud Pharma has entered into a licensing development manufacturing and commercialisation agreement with Sandoz for an emicizumab
Orbis Medicines enters multi-target drug discovery partnership with Novo Nordisk
Orbis Medicines has entered a strategic collaboration and licence agreement with Novo Nordisk to discover and develop nextgeneration oral macrocycle medicines for cardiometabolic diseases
Everest Clinical Research expands global biometrics capabilities with Firma DS acquisition
Everest Clinical Research has acquired the Biometrics and Data Services business unit of Firma Clinical Research expanding its global biometrics expertise and clinical data science capabilities
Novo Nordisk and Anthropic collaborate to advance AI-led drug discovery
Novo Nordisk and Anthropic have announced a collaboration to accelerate drug discovery and development using artificial intelligence AI while also expanding AIsupported software development at Novo
Twist Bioscience joins Lilly TuneLab to support antibody drug discover
Twist Bioscience has entered into an agreement with Lilly TuneLab an artificial intelligence and machine learning AIML drug discovery platform developed by Eli Lilly and Company





